🇺🇸 FDA
Patent

US 10086084

Activated polyoxazolines and conjugates and compositions comprising the same

granted A61KA61K31/727A61K31/728

Quick answer

US patent 10086084 (Activated polyoxazolines and conjugates and compositions comprising the same) held by Serina Therapeutics, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/727, A61K31/728, A61K38/10, A61K38/1719